Skip to content
Tenfell
Closed tender
Published 28 Sep 2025

Contract for the Provision for the Manufacture of Vaccine Antigen

University College Dublin ( UCD ) · Ireland

Key facts

Estimated value
€100,000
Closing date
15 Oct 2025
Procedure
Open procedure
Buyer type
Education

Description

UCD has developed a series of bacterial antigens which have proven effective in proof-of-concept studies and which the aim is to further develop and translate to humans. The lead target antigen is 22 kDa cytosolic bacterial protein and is currently His-tagged to facilitate affinity purification. UCD have developed a lab-scale expression and purification protocol, which will be provided to the successful contractor. We require contract protein manufacture and purification services. The purpose of the work is to appropriately scale-up the antigen to produce ~200mg batches of protein at a standard that will confirm feasibility of technology transfer and that can be used in GLP toxicology studies in mice, to ensure safety of the developed product. Ultimately, UCD would like the process to be amenable to production in a GMP facility in the future.

Categories (CPV)

Similar open tenders

About University College Dublin ( UCD )

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on TED (Tenders Electronic Daily) (EU open data (Decision 2011/833/EU)). Always read the original notice before responding.